Trial · NCT04512053
A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence
NCT04512053, Phase 2, Completed, Taiho Pharmaceutical Co., Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence. Trials, record NCT04512053. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04512053
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence
- NCT number
- NCT04512053
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 231 participants, actual
- Lead sponsor
- Taiho Pharmaceutical Co., Ltd.
- Conditions
- Stress Urinary Incontinence
- Interventions
- TAS-303 18 mg/day, Placebo
- First posted
- 2020-08-13
- Last updated
- 2022-02-10
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The percent change in the average SUI episode frequency per 24 hours | Baseline, week 12 | |
| Secondary | The average urinary incontinence episode frequency per 24 hours | Baseline, week 4, week 8, week 12 | |
| Secondary | The urinary incontinence volume measured in a 24-hour pad test | Baseline, week 12 | |
| Secondary | The change in the international Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) | Baseline, week 4, week 8, week 12 | |
| Secondary | The change in the Patient's Global Impressions of Improvement (PGI I) questionnaire. | Baseline, week 4, week 8, week 12 | |
| Secondary | The change in the incontinence quality of life instrument (I QOL) scores | Baseline, week 4, week 8, week 12 | The minimum score is 22 points and the maximum is 110 points. The higher scores mean a worse outcome. |
| Secondary | The changes in the overactive bladder symptom score (OABSS) | Baseline, week 4, week 8, week 12 | The minimum score is 0 points and the maximum is 15 points. The higher scores mean a worse outcome. |
| Secondary | Incidence of adverse events and side effects | Up to 13 Weeks |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 38979756 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04512053
GET https://conductscience.org/api/trials/v1/NCT04512053/registered